RG
RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
$0.00 +0.00% (+$0.00)
1M +57.14%
Market Cap $898.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.01x
EV/EBITDA N/A
P/B N/A
Growth
20 /100
Declining Rev. growth 0.00%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 2,249.84%
Op. margin 1,826.45%
FCF margin 1,225.52%
Quality
61 /100
Average ROA 451.89%
Asset turnover 0.20x
ROIC 1,654.75%
Debt
52 /100
Moderate Int. coverage -4.31x
Net debt/EBITDA -0.82x
Current ratio 0.55x
Stability
31 /100
Unstable Rev. volatility 0.00%
EPS volatility 4,091.19%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RGRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. J. Finkelstein
Employees
2
Headquarters
Rockville